Multicenter, Prospective Observational Study for Early Diagnosis, and Development of Follow-up Protocol and Hearing Rehabilitation Program for Ototoxic Hearing Loss After Chemotherapy for Pediatric Solid Cancer

Solid Tumor, Childhood Clinical Trial

Official title:
Multicenter, Prospective Observational Study for Early Diagnosis, and Development of Follow-up Protocol and Hearing Rehabilitation Program for Ototoxic Hearing Loss After Chemotherapy for Pediatric Solid Cancer

Status Not yet recruiting

Clinical Trial Summary

More than half of all pediatric cancer in Korea are solid cancer. For the treatment of solid cancer, multidisciplinary methods such as surgery, chemotherapy, and radiation therapy are applied, and with the development of the treatment method, the treatment performance has improved dramatically, and the 5-year survival rate of more than 80% is currently recorded. Due to the improvement in survival rate, interest in side effects caused by cancer treatment itself is gradually increasing, and efforts to reduce them are increasing. Accordingly, it aims to contribute to improving the quality of life of pediatric solid cancer survivors. by developing a Korean-type early diagnosis and follow-up protocol of ototoxic hearing loss, which commonly occurs in pediatric solid cancer who have undergone chemotherapy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05633719
Study type	Observational [Patient Registry]
Source	Seoul National University Hospital
Contact
Status	Not yet recruiting
Phase
Start date	December 1, 2022
Completion date	June 30, 2026

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03936465` - Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer	Phase 1
Recruiting	`NCT04899505` - Evaluation of the Impact of Chemotherapy on Body Odor in Adolescents and Young Adults in Oncology
Recruiting	`NCT03465592` - Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma	Phase 1/Phase 2
Recruiting	`NCT03373656` - Vaccination for Children of H&O and Their Parents	N/A
Recruiting	`NCT05481502` - An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors	N/A
Recruiting	`NCT05042479` - Using of Virtual Reality to Relieve Procedural Pain in Pediatric Oncology.	N/A
Recruiting	`NCT04471961` - Analyse of Tumour and Constitutional DNA for the Study of the Determinism in Child Neoplasia	N/A
Recruiting	`NCT04485416` - Pilot Trial of Eltrombopag in Patients Undergoing Chemotherapy for Malignant Solid Tumors	Phase 1
Recruiting	`NCT03086421` - Social Emotional Development in Young Children With Cancer
Recruiting	`NCT04381221` - Observational MyPal-Child Study on the ePRO-based Early Palliative Care Digital System in Paediatric Oncology Patients
Terminated	`NCT04671901` - A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors	Phase 2